Serum IL-22 concentration was comparable between NCs and lung adenocarcinoma patients (78.27 ± 12.47 compared with 79.78 ± 10.96 pg/ml, P=0.686, Figure 2A). The gene discussed is IL22; the disease is lung adenocarcinoma.